Ticker Details
Humacyte, Inc. Common Stock
IPO Date:	November 30, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$178.4M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.18 | 4.52%
Avg Daily Range (30 D):	$0.03 | 4.14%
Avg Daily Range (90 D):	$0.05 | 5.59%

Institutional Daily Volume
Avg Daily Volume:	2.55M
Avg Daily Volume (30 D):	7.28M
Avg Daily Volume (90 D):	8.76M

Trade Size
Avg Trade Size (Sh.):	259
Avg Trade Size (Sh.) (30 D):	556
Avg Trade Size (Sh.) (90 D):	513

Institutional Trades
Total Institutional Trades:	314
Avg Institutional Trade:	$1.48M
Avg Institutional Trade (30 D):	$.57M
Avg Institutional Trade (90 D):	$1.86M
Avg Institutional Trade Volume:	.41M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.61M
Avg Closing Trade (30 D):	$.57M
Avg Closing Trade (90 D):	$2.63M
Avg Closing Volume:	435.18K

News

Jul 14, 2026 @ 12:00 PM Humacyte Appoints Key Nephrologists as Advisors to... Source: Na

Jun 11, 2026 @ 1:08 AM Humacyte, Inc. Announces Pricing of Public Offerin... Source: Globe Newswire

Jun 11, 2026 @ 1:08 AM Humacyte, Inc. Announces Pricing of Public Offerin... Source: Not Specified

Jun 11, 2026 @ 12:55 AM Humacyte, Inc. Announces Proposed Public Offering ... Source: Na

May 13, 2026 @ 11:00 AM Humacyte Announces First Quarter 2026 Financial Re... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.16	$-.09	$-.15
Diluted EPS	$-.16	$-.09	$-.15
Revenue	$.41M	$.5M	$.47M
Gross Profit	$-.83M	$-1.54M	$-8.62M
Net Income / Loss	$-36.8M	$-17.62M	$-24.8M
Operating Income / Loss	$-27M	$-28.94M	$-30.84M
Cost of Revenue	$1.23M	$2.04M	$9.08M
Net Cash Flow	$31.36M	$-1.96M	$31.01M
PE Ratio